Chinese medical device maker Mindray launches new diagnostic ultrasound system

Shenzhen-listed medical devices developer Mindray has introduced its latest imaging diagnostic ultrasound system called Resona I9.

In a press release, the company said the new device features a customisable control panel, foldable structure to a height of one meter, extended battery life and a "silent" design. It also said the device helps reduce fatigue during scans.

Resona I9 is powered by Mindray's ZST+ platform, which enables the delivery of "exceptional" image quality for infinite imaging solutions. It is also equipped with Smart Breast and Smart Thyroid automatic standard lesion analysis that shortens examination times.

"Resona I9 has evolved with the changing demands of diagnostic imaging and includes a suite of innovative features," said He Xujin, general manager of Mindray's Imaging System division.

Filipino HMO Intellicare taps UnionBank for doctor's payroll

Asalus Corporation (Intellicare), a health maintenance organisation in the Philippines, has partnered with Union Bank of the Philippines for opening payroll accounts of its affiliated doctors.

In a statement, Intellicare said opening UnionBank's ePaycard digital accounts will help hasten the disbursement of professional fees, benefits and other reimbursements of affiliated doctors. The opening of the digital payroll accounts is done in real-time upon Intellicare's approval.

UnionBank offers an account opening facility that is "efficient, paperless, and with a fully digital disbursement solution for the convenience of Intellicare affiliated doctors", it said.

"It is Intellicare's desire to always consider the best for our partner doctors and medical facilities to ensure the efficient flow in the supply chain. This payment facility of UnionBank is an enabler for us to meet our commitments to them in the best way possible amid the challenges of less physical contact in managing the pandemic," Intellicare EVP Audrey Meldy Gallardo said.

"[T]he bank has made it its goal to aid companies and its employees in making the disbursement process more efficient, convenient and safe for all those involved in the transaction," Mary Joyce Gonzales, UnionBank's head of retail banking, also stated.

World Bank Group's IFC, Mitsui to invest $60M in MiCare

Singapore-based MiCare, a subsidiary of healthcare service giant Zuellig Pharma, recently announced the combined $60 million investment of World Bank Group's International Finance Corporation and the Asia-Pacific unit of trade firm Mitsui & Co. in the company.

The company said in a statement that the strategic investment will be used for its expansion in key markets in Southeast Asia, including Indonesia and Vietnam. It will also use the funds to set up a new regional headquarters in Singapore.

"This investment will help us continue enhancing our client offerings by strengthening our digital capabilities and enabling us to introduce innovative solutions through partnerships with healthcare ecosystem players such as pharma and telemedicine companies," MiCare Founder and Group CEO Moses Hee said.

"Our investment in MiCare will help bring robust medical claims administration processes and advanced proprietary digital tools to underserved markets in Southeast Asia, supporting insurers and providers with the technological tools needed for more efficient and effective healthcare delivery," Rana Karadsheh, a regional industry director at IFC Asia-Pacific, also said.

Using a digital platform powered by an AI fraud detection engine and predictive analytical tools, MiCare administers, processes and manages medical claims on behalf of insurers and self-insured corporate clients. It processes $400 million medical claims each year for over 45 insurance firms and 6,500 corporate clients in more than 5,000 hospitals, clinics and pharmacies.

The company also builds applications that connect stakeholders and facilitate seamless and efficient medical claims management.

Trivitron Healthcare unveils latest diagnostic solutions for diabetes monitoring

India-based medical device maker Trivitron Healthcare has launched two new diagnostic products for monitoring diabetes, thalassemia and haemoglobin variants.

NANO H5 and NANO H110 are compact and automated high-performance liquid chromatography (HPLC) analysers that can detect glycated haemoglobin (HbA1c), a key indicator of blood sugar, in "less than 3 minutes".

"[K]eeping in mind the increasing concern for [the] management of diabetes and the growing demand for accurate measurement of HbA1c level, we are delighted to announce the launch of HPLC-based HbA1c analysers – NANO H5 and NANO H110 – that are compact and designed for precision," Trivitron Healthcare CEO Rajesh Patel said in a statement.